Evidence map›Paper›PMID 33313998›Full record

ArticleDermatology and therapy2021

Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia.

David Luk, Kam Lun Ellis Hon, Maria Victoria C Dizon, Kin-Fon Leong, Yong-Kwang Tay, Mark Jean-Aan Koh, Nisha Suyien Chandran, Siriwan Wananukul, Susheera Chatproedprai, Thomas Luger

Open access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Experimental Drugs with the Potential to Treat Atopic Eczema.Journal of experimental pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 7 countries.

David LukDepartment of Paediatric and Adolescent Medicine, United Christian Hospital, Kwun Tong , Hong Kong SAR, People's Republic of China.
Kam Lun Ellis HonDepartment of Paediatrics, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
Maria Victoria C DizonDepartment of Dermatology, University of Santo Tomas, Manila, Philippines.
Kin-Fon LeongKuala Lumpur General Hospital, Kuala Lumpur, Malaysia.
Yong-Kwang TayDepartment of Dermatology, Changi General Hospital, Singapore, Singapore.
Mark Jean-Aan KohDermatology Service, KK Women's and Children's Hospital, Singapore, Singapore.
Nisha Suyien ChandranDivision of Dermatology, Department of Medicine, National University Hospital, Singapore, Singapore.
Siriwan WananukulDepartment of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Susheera ChatproedpraiDepartment of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Thomas LugerDepartment of Dermatology, University of Münster, Münster, Germany. luger@uni-muenster.de.ORCID http://orcid.org/0000-0003-1397-1626
Chulalongkorn University · THChangi General Hospital · SGChinese University of Hong Kong · HKHospital Kuala Lumpur · MYKK Women's and Children's Hospital · SGNational University Hospital · SGUnited Christian Hospital · CNUniversity of Münster · DEUniversity of Santo Tomas · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is some evidence to suggest that the prevalence of atopic dermatitis (AD) in Asia is rising. We have therefore developed an algorithm for the topical treatment of AD throughout South and East Asia for use by primary care physicians, pediatricians and dermatologists.

methodsNine AD experts from South and East Asia and one from Europe developed the algorithm based upon treatment guidelines, relevant literature and local treatment practices. The algorithm outlines current best practice for the use of emollients, topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI), with the intention of simplifying the treatment regimen of mild-to-moderate AD in South and East Asia.

resultsPatients with AD should bathe and cleanse affected skin to remove crusts and scales daily. Emollients should also be applied daily as a maintenance treatment. When selecting appropriate topical anti-inflammatory treatment for AD flares, several factors should be taken into consideration, including the patient's age, attitude to treatment options and site of AD lesions. Given the concerns regarding the risk of skin atrophy with use of TCS, a TCI should be used to treat AD lesions in sensitive skin areas: pimecrolimus is recommended for mild-to-moderate AD in these locations, while tacrolimus should be considered for moderate and severe cases. Either pimecrolimus or tacrolimus is recommended for flares in other, non-sensitive body locations. A proactive or intermittent maintenance treatment strategy involving regular emollient use and twice-weekly application of a TCI to previously affected areas is encouraged to reduce the risk of flares.

conclusionsThe algorithm proposed here is intended to simplify the topical treatment of mild-to-moderate AD in daily practice in South and East Asian countries.

Indexed as

AlgorithmAtopic dermatitisPimecrolimusSouth and East AsiaTacrolimus

Identifiers

PMID33313998
PMCPMC7859143
OpenAlexW3111986875

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.